Skip to main content
SpringerLink
Log in

Cardiometabolic Syndrome and Effects of Yoga

  • Chapter
  • First Online:
The Principles and Practice of Yoga in Cardiovascular Medicine

  • 478 Accesses

Abstract

Growing body of current evidence indicates that the prevalence of cardiometabolic risk factors is increasing at an alarming rate in both developed and developing countries. Unhealthy lifestyle, inappropriate diet, mental stress, and physical inactivity are the main reason behind the epidemic proportion of this problem. Cardiometabolic syndrome (CMS) is a combination of metabolic dysfunctions mainly characterized by insulin resistance, impaired glucose tolerance, dyslipidemia, hypertension, and central adiposity. CMS is now recognized as a disease entity by the World Health Organization and the American Society of Endocrinology. Accumulated evidence subscribes to the fact that metabolic syndrome and its component may have a strong psychosomatic component. Thus stress, anxiety and other aberrant mental states can not only generate but sustain and propagate these disorders. Thus complementary medicine therapy particularly yoga which includes lifestyle modification, dietary changes, stress reduction through meditation and physical exercise through 'asanas' has been suggested as both a preventive and a therapeutic modality. Therefore, the purpose of writing this chapter is to discuss the present condition and scenario of metabolic diseases over the globe and how yoga in the form of lifestyle intervention will be helpful to reduce the risk of metabolic dysfunctions. This chapter elucidates the meaning and clinical aspects of this disease and discusses the role of yoga in prevention and therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. World Health Organization. WHO global recommendations on physical activity for health. Geneva: World Health Organization; 2010.

    Google Scholar 

  2. Riebe D, Franklin BA, Thompson PD, Garber CE, Whitfield GP, Magal M, Pescatello LS. Updating ACSM’s recommendations for exercise preparticipation health screening. Medicine & Science in Sports & Exercise. Copyright 2015 by the American College of Sports Medicine.

    Google Scholar 

  3. 2018 Physical Activity Guidelines Advisory Committee. 2018 Physical Activity Guidelines Advisory Committee scientific report [Internet] [cited 2019 Apr 29]. Rockville MD. U.S. Department of Health and Human Services; 2018. Available from https://health.gov/paguidelines/second-edition/report/.

  4. Cotman CW, Berchtold NC, Christie LA. Exercise builds brain heakey roles of growth factor cascades and inflammation. Trends Neurosci. 2007;30(9):464–72.

    Article  CAS  PubMed  Google Scholar 

  5. Dishman RK, O’Connor PJ. Lessons in exercise neurobiology: the case of endorphins. Mental Health Phys Activity. 2009;2(1):4–9.

    Article  Google Scholar 

  6. WHO. Noncommunicable diseases progress monitor, vol. 46. Geneva: World Health Organization; 2017.

    Google Scholar 

  7. WHO. Global status report on noncommunicable diseases: “Attaining the nine global noncommunicable disease targets; a shared responsibility.”. World Health Organization, Geneva, Switzerland; 2014.

    Google Scholar 

  8. Baygi F, Herttua K, Jensen OC, Djalalinia S, Ghorabi AM, Asayesh H, Qorbani M. Global prevalence of cardiometabolic risk factors in the military population: a systematic review and meta-analysis. BMC Endocrine Disorders. 2020;20:8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Einarson TR, Acs A, Ludwig C, Pantom UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol. 2018;17:83.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Hajar R. Risk factors for coronary artery disease: historical perspectives. Heart Views. 2017 Jul–Sep;18(3):109–14.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Gundu HR. Cardiometabolic diseases: a global perspective. J Cardiol Cardiovasc Ther. 2018;12(2):555834.

    Google Scholar 

  12. Gallagher EJ, LeRoith D, Karnieli E. The metabolic syndrome—from insulin resistance to obesity and diabetes. Endocrinol Metab Clin N Am. 2008;37:559–79.

    Article  CAS  Google Scholar 

  13. Kraemer FB, Ginsberg HN, Reaven GM. Demonstration of the central role of insulin resistance in type 2 diabetes and cardiovascular disease. Diabetes Care. 2014 May;37(5):1178–81.

    Article  PubMed  Google Scholar 

  14. Himsworth H. Diabetes Mellitus: a differentiation into insulin-sensitive and insulin-insensitive types. Lancet. 1936;1:127–30.

    Article  Google Scholar 

  15. National Diabetes Data Group. Report of the expert committee on glucosylated hemoglobin. Dibets Care. 1984;7:602–6.

    Article  Google Scholar 

  16. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595–607.

    Article  CAS  PubMed  Google Scholar 

  17. Vecchio I, Tornali C, Bragazzi NL, Martini M. The discovery of insulin: an important milestone in the history of medicine. Front Endocrinol (Lausanne). 2018 Oct 23;9:613.

    Article  Google Scholar 

  18. Unwin N. The metabolic syndrome. J R Soc Med. 2006 Sep;99(9):457–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–53.

    Article  CAS  PubMed  Google Scholar 

  20. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999;16:442–3.

    Article  CAS  PubMed  Google Scholar 

  21. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–97.

    Article  Google Scholar 

  22. Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, Hellman R, Jellinger PS, Kendall D, Krauss RM, Neufeld ND, Petak SM, Rodbard HW, Seibel JA, Smith DA, Wilson PW. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2003;9:237–52.

    Article  PubMed  Google Scholar 

  23. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome: a new worldwide definition. Lancet. 2005;366:1059–62.

    Article  PubMed  Google Scholar 

  24. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol. 2004;24:e13–8.

    CAS  PubMed  Google Scholar 

  25. Kassi E, Pervanidou P, Kaltsas G, Chrousos G. Metabolic syndrome: definitions and controversies. BMC Medicine. 2011;9:48.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–5.

    Article  CAS  PubMed  Google Scholar 

  27. Chatterjee A, Harris SB, Leiter LA, Fitchett DH, Teoh H, Bhattacharyya. Managing cardiometabolic risk in primary care: Summary of the 2011 consensus statement. Can Family Phys. 2012;58:389–93.

    Google Scholar 

  28. Eriksson J, Taimela S, Koivisto VA. Exercise and metabolic syndrome. Diabetologia. 1997;40:125–35.

    Article  CAS  PubMed  Google Scholar 

  29. Bhavanani AB. Role of yoga in prevention and management of lifestyle disorders. Yoga Mimamsa. 2017;49:42–7.

    Article  Google Scholar 

  30. Bijlani RL, Vempati RP, Yadav RK, Ray RB, Gupta V, Sharma R, et al. A brief but comprehensive lifestyle education program based on yoga reduces risk factors for cardiovascular disease and diabetes mellitus. J. Altern Complement Med. 2005;11:267–74.

    Article  PubMed  Google Scholar 

  31. Physical Activity Guidelines Advisory Committee Report, 2008. To the Secretary of Health and Human Services. Part A: executive summary. Nutr Rev. 2009;67:114–20.

    Article  Google Scholar 

  32. Guthold R, Stevens GA, Riley LM, Bull FC. Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1·9 million participants. Lancet Glob Health. 2018;6:e1077–86.

    Article  PubMed  Google Scholar 

  33. Vincent GE, Jay SM, Sargent C, Vandelanotte C, Ridgers ND, Ferguson SA. Improving cardiometabolic health with diet, physical activity, and breaking up sitting: what about sleep? Front Physiol. 2017 Nov 8;8:865.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Grundy SM, Brewer HB Jr, Cleeman JI, et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433–8.

    Article  PubMed  Google Scholar 

  35. Lawlor DA, Ebrahim S, Davey SG. The metabolic syndrome and coronary heart disease in older women. Findings from the British Women’s Heart and Health Study. Diabetic Med. 2004;21:906–13.

    Article  CAS  PubMed  Google Scholar 

  36. Ravikiran M, Bhansali A, Ravikumar P, Bhansali S, Dutta P, Thakur JS, et al. Prevalence and risk factors of metabolic syndrome among Asian Indians: a community survey. Diabetes Res Clin Pract. 2010;8:269–73.

    Google Scholar 

  37. Colley RC, Garriguet D, Janssen I, Craig CL, Clarke J, Tremblay MS. Physical activity of Canadian adults: accelerometer results from the 2007 to 2009 Canadian Health Measures Survey. Health Rep. 2011;22:7.

    PubMed  Google Scholar 

  38. Killgore WD. Human sleep and cognition: basic research. In: Kerkhof GA, Van Dongen HPA, editors. Progress in brain research, vol. 185. New York: Elsevier Science; 2010. p. 105–29.

    Google Scholar 

  39. Copinschi G, Leproult R, Spiegel K. The important role of sleep in metabolism. Front Horm Res. 2014;42:59–72.

    Article  PubMed  Google Scholar 

  40. Knutson KL. Impact of sleep and sleep loss on glucose homeostasis and appetite regulation. Sleep Med Clin. 2007;2:187–97.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Besedovsky L, Lange T, Born J. Sleep and immune function. Pflügers Arch Eur J Physiol. 2012;463:121–37.

    Article  CAS  Google Scholar 

  42. Steiger A. Sleep and endocrine regulation. Front Biosci. 2003;8:s358–76.

    Article  CAS  PubMed  Google Scholar 

  43. Watson N, Badr M, Belenky G, Bliwise D, Buxton O, Buysse D, et al. Recommended amount of sleep for a healthy adult: a joint consensus statement of the American Academy of Sleep Medicine and Sleep Research Society. J Clin Sleep Med. 2015;38:843–4.

    Google Scholar 

  44. Centers for Disease Control Prevention. Unhealthy sleep-related behaviors 12 States, 2009. MMWR. 2011;60:233.

    Google Scholar 

  45. Schmid SM, Hallschmid M, Schultes B. The metabolic burden of sleep loss. Lancet Diabetes Endocrinol. 2015;3:52–62.

    Article  CAS  PubMed  Google Scholar 

  46. Manjunath NK, Telles S. Influence of yoga and Ayurveda on self-rated sleep in a geriatric population. Indian J Med Res. 2005;121(5):683–90.

    CAS  PubMed  Google Scholar 

  47. Patra S, Telles S. Positive impact of cyclic meditation on subsequent sleep. Med Sci Monit. 2009;15(7):CR375–81.

    PubMed  Google Scholar 

  48. Ebrahimi M, Guilan-Nejad TN, Pordanjani AF. Effect of yoga and aerobics exercise on sleep quality in women with Type 2 diabetes: a randomized controlled trial. Sleep Sci. 2017 Apr–Jun;10(2):68–72.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Xu H, Li X, Hannah A, Kubena K, Guo S. Etiology of metabolic syndrome and dietary intervention. Int J Mol Sci. 2018 Dec 31;20(1):128.

    Article  PubMed Central  CAS  Google Scholar 

  50. Untangle food industry influences on health. Nat Med 2019;25:1629.

    Google Scholar 

  51. Swami D, Kokaje RS. Hatha pradipika of Svatmarama. 2nd ed. Lonavla, Pune, India: Kaivalyadhama, S.M.Y.M. Samiti; 1998.

    Google Scholar 

  52. Ramos-Jiménez A, Wall-Medrano A, Corona-Hernández RI, Hernández-Torres RP. Yoga, bioenergetics and eating behaviors: A conceptual review. Int J Yoga. 2015 Jul-Dec;8(2):89–95.

    Article  PubMed  PubMed Central  Google Scholar 

  53. McIver S, McGartland M, O’Halloran P. Overeating is not about the food: women describe their experience of a yoga treatment program for binge eating. Qual Health Res. 2009;19:1234.

    Article  PubMed  Google Scholar 

  54. Carei TR, Fyfe-Johnson AL, Breuner CC, Brown MA. Randomized controlled clinical trial of yoga in the treatment of eating disorders. J Adolesc Health. 2010;46:346–51.

    Article  PubMed  Google Scholar 

  55. Jhon W, Newcomer MD. Metabolic syndrome and mental illness. Am J Manag Care. 2017;13:S170–7.

    Google Scholar 

  56. Li R, Jia Z, Trush MA. Defining ROS in biology and medicine. React Oxyg Species (Apex). 2016;1(1):9–21.

    Article  Google Scholar 

  57. Forrester SJ, Kikuchi DS, Hernandes MS, Xu Q. Griendling. Reactive oxygen species in metabolic and inflammatory signaling. Circ Res. 2018;122(6):877–902.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Simioni C, Zauli G, Martelli AM, Vitale M, Sacchetti G, Gonelli A, Neri LM. Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging. Oncotarget. 2018;9(24):17181–98.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Krikwood K, Rampes H, Tuffery V, Richardson J, Pilkington K. Yoga for anxiety: a systematic review of the research. Br J Sports Med. 2005;39:884–91.

    Article  Google Scholar 

  60. Mehta P, Sharma M. Yoga as a therapy for clinical depression. Complement Health Pract Rev. 2010;15(3):156–70.

    Article  Google Scholar 

  61. Wallace RK, Benson H, Wilson AF. A wakeful hypometabolic physiologic state. Am J Physiol. 1971;221:795–9.

    Article  CAS  PubMed  Google Scholar 

  62. Benson H, Beary JF, Carol MP. The relaxation response. Psychiatry. 1974;37:37–46.

    Article  CAS  PubMed  Google Scholar 

  63. Riley KE, Park CL. How does yoga reduce stress? A systematic review of mechanisms of change and guide to future inquiry. Health Psychol Rev. 2015;9(3):379–96.

    Article  PubMed  Google Scholar 

  64. Telles S, Singh N, Gupta RK, Balkrishna A. A selective review of dharana and dhyana in healthy participants. J Ayurveda Integr Med. 2016;7(4):255–60.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Dunn SL, Siu W, Freund J, Boutcher SH. The effect of a lifestyle intervention on metabolic health in young women. Diabetes Metab Syndr Obes. 2014 Sep 19;7:437–44.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Ki NK, Lee HK, Cho JH, Kim SC, Kim NS. Factors affecting metabolic syndrome by lifestyle. J Phys Ther Sci. 2016;28(1):38–45.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Vancampfort D, Hallgren M, Mugisha J, Hert MD, Probst M, Monsieur D, Stubbs B. The Prevalence of metabolic syndrome in alcohol use disorders: a systematic review and meta-analysis. Alcohol Alcohol. 2016;51(5):515–21.

    Article  PubMed  Google Scholar 

  68. Kuppili PP, Parmar A, Gupta A, Balhara YPS. Role of yoga in management of substance-use disorders: a narrative review. J Neurosci Rural Pract. 2018 Jan–Mar;9(1):117–22.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Kirk EP, Klein S. Pathogenesis and pathophysiology of the cardiometabolic syndrome. J Clin Hypertens (Greenwich). 2009;11(12):761–5.

    Article  CAS  Google Scholar 

  70. Castro JP, El-Atat FA, McFarlane SI, Aneja A, Sowers JR. Cardiometabolic syndrome: pathophysiology and treatment. Curr Hypertens Rep. 2003;5(5):393–401.

    Article  PubMed  Google Scholar 

  71. Blaton V. How is metabolic syndrome related to the dyslipidemia? EJIFCC. 2007 Feb;18(1):15–22.

    PubMed  PubMed Central  Google Scholar 

  72. Ebbert JO, Jensen MD. Fat depots, free fatty acids, and dyslipidemia. Nutrients. 2013 Feb;5(2):498–508.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Gadde KM, Martin CK, Berthoud HR, Heymsfield SB. Obesity: pathophysiology and management. J Am Coll Cardiol. 2018;71(1):69–84.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Ruotolo G, Howard BV. Dyslipidemia of the metabolic syndrome. Curr Cardiol Rep. 2002 Nov;4(6):494–500.

    Article  PubMed  Google Scholar 

  75. Shapiro MD, Fazio S. Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease. F1000Res. 2017 Feb 13;6:134.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  76. Carson JS, Lichtenstein AH, Anderson CA, Appel LJ, Kris-Etherton PM, Meyer KA, Petersen K, Polonsky T, Horn LV. Dietary cholesterol and cardiovascular risk: a science advisory from the American Heart Association. Circulation. 2020;141:e39–53.

    Article  PubMed  Google Scholar 

  77. Sperling LS, Mechanick JI, Neeland IJ, et al. The Cardio Metabolic Health Alliance: working toward a new care model for metabolic syndrome. J Am Coll Cardiol. 2015;66(9):1050–67.

    Article  PubMed  Google Scholar 

  78. Priest C, Tontonoz P. Inter-organ cross-talk in metabolic syndrome. Nat Metab. 2019;1:1177–88.

    Article  PubMed  Google Scholar 

  79. Kim JH. Increased serum angiopoietin-like 6 ahead of metabolic syndrome in a prospective cohort study. Diabetes Metab J. 2019;43:521–9.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Berger A. Resistin: a new hormone that links obesity with type 2 diabetes. BMJ. 2001 Jan 27;322(7280):193.

    PubMed Central  Google Scholar 

  81. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CW, Patel HR, Ahima RS, Lazar MA. The hormone resistin links obesity to diabetes. Nature. 2001;409(6818):307–12.

    Article  CAS  PubMed  Google Scholar 

  82. Han C, Rice MW, Cai D. Neuroinflammatory and autonomic mechanisms in diabetes and hypertension. Am J Physiol Endocrinol Metab. 2016 Jul 1;311(1):E32–41.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Münzberg H, Qualls-Creekmore E, Berthoud HR, Morrison CD, Yu S. Neural control of energy expenditure. Handb Exp Pharmacol. 2016;233:173–94.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  84. Xu Y, Zhang Y, Ye J. IL-6: a potential role in cardiac metabolic homeostasis. Int J Mol Sci. 2018 Aug 21;19(9):2474.

    Article  PubMed Central  CAS  Google Scholar 

  85. Huang Z, Chen X, Chen D. Myostatin: a novel insight into its role in metabolism, signal pathways, and expression regulation. Cell Signal. 2011 Sep;23(9):1441–6.

    Article  CAS  PubMed  Google Scholar 

  86. Longhi S, Radetti G. Thyroid function and obesity. J Clin Res Pediatr Endocrinol. 2013;5(Suppl 1):40–4.

    PubMed  PubMed Central  Google Scholar 

  87. Sanyal D, Raychaudhuri M. Hypothyroidism and obesity: an intriguing link. Indian J Endocrinol Metab. 2016 Jul–Aug;20(4):554–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. Ibrahim Abdalla MM. Ghrelin - physiological functions and regulation. Eur Endocrinol. 2015 Aug;11(2):90–5.

    Article  PubMed  PubMed Central  Google Scholar 

  89. Ndumele CE, Pradhan AD, Ridker PM. Interrelationships between inflammation, C-reactive protein, and insulin resistance. J Cardiometab Syndr. 2006;1(3):190–6.

    Article  PubMed  Google Scholar 

  90. Kuvalayananda S, Vinekar SL. Yogic therapy basic principles and methods. Twari OP, Kaivalyadhama, Lonavla, India; 2019 (reprinted).

    Google Scholar 

  91. Nagarathna R, Nagendra HR. Yoga for hypertension and heart diseases. 2002 (reprinted). Bangalore, India: Vivekananda Yoga Research Foundation, Swami Vivekananda Yoga Prakashana.

    Google Scholar 

  92. Bhavanani AB. Yoga: The original mind body medicine. 2012. https://www.researchgate.net/publication/237077700

  93. Bhavanani AB. Yoga is not an intervention but may yogopathy is. J Yoga. 2012;5(20):157–8.

    Article  Google Scholar 

  94. Nagarathna R, Nagendra HR. Integrated approach of yoga therapy for positive health. Bangalore, India: Swami Vivekananda Yoga Prakashana; 2006.

    Google Scholar 

  95. Saraswati SM. Prana Pranayama Prana Vidya. Munger, Bihar, India: Yoga Publication Trust; 2002.

    Google Scholar 

  96. Rosmand R, Dallman MF, Bjorntorn P. Stress related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. Clin Endocrinol Metab. 1998;83(6):1853–9.

    Google Scholar 

  97. Bhavanani AB. Yogic perspectives of mental health. Ann SBV. 2014;3(1):47–52.

    Article  Google Scholar 

  98. Mumukshananda S. Meditation and its preparation. Kolkata, India: The Ramakrishna Mission Institute of Culture; 2000.

    Google Scholar 

  99. Bjorntorp P. Neuroendocrine factors in obesity. J Endocrinol. 1997;155:193–5.

    Article  CAS  PubMed  Google Scholar 

  100. Björntorp P. The regulation of adipose tissue distribution in humans. Int J Obes Relat Metab Disord. 1996;20:291–302.

    PubMed  Google Scholar 

  101. Kyrios M, Moore SM, Hackworth N, Buzwell SA, Crafti N, Critchley C, et al. The influence of depression and anxiety on outcomes after an intervention for prediabetes. Med J Aust. 2009;190:S81–5.

    Article  PubMed  Google Scholar 

  102. Dhananjai S, Sadashiv TS, Kumar R. Effect of a yoga practice in the management of risk factors associated with obesity: a pilot study. ISRJ. 2011;1:1–4.

    Google Scholar 

  103. Sohl SJ, Wallston KA, Watkins K, Birdee GS. Yoga for risk reduction of metabolic syndrome: patient reported outcomes from a randomized controlled pilot study. Evid Based Complement Alterat Med. 2016;2016:3094589.

    Google Scholar 

  104. Teychenne M, Ball K, Salmon J. Associations between physical activity and depressive symptoms in women. Int J Behav Nutr Phys Act. 2008;5:27.

    Article  PubMed  PubMed Central  Google Scholar 

  105. Dunn AL, Trivedi MH, Kampert JB, Clark CG, Chambliss HO. Exercise treatment for depression: efficacy and dose response. Am J Prev Med. 2005;28:1–8.

    Article  PubMed  Google Scholar 

  106. WHO Expert Consultation. Appropriate body mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–63.

    Article  Google Scholar 

  107. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab. 2004;89:2583–9.

    Article  CAS  PubMed  Google Scholar 

  108. Taittiriyopanisad SS. Ch. 2: 1-6. Chennai: Shree Ramakrishna Publication; 2008. p. 88–134.

    Google Scholar 

  109. Hatha S. Yoga Pradipika of Svatmarama. Adyar: Adyar Library and Research Centre; 1994.

    Google Scholar 

  110. Digambarji S, Gharote ML. Gherenda Samhita. Lonavla: SMYM Samiti; 1978.

    Google Scholar 

  111. Parshad O. Role of yoga in stress management. West Indian Med J. 2004;53(3):191–4.

    CAS  PubMed  Google Scholar 

  112. Yadav RK, Magan D, Mehta N, Sharma R, Mahapatra SC. Efficacy of a short term yoga based lifestyle intervention in reducing stress and inflammation: preliminary results. J Altern Complement Med. 2012;18:662–7.

    Article  PubMed  Google Scholar 

  113. Cozzolino D, Sasso FC, Cataldo D, Gruosso D, Giammarco A, Cavalli A, et al. Acute pressor and hormonal effects of beta-endorphin at high doses in healthy and hypertensive subjects: role of opioid receptor agonism. J Clin Endocrinol Metab. 2005;90:5167–74.

    Article  CAS  PubMed  Google Scholar 

  114. Rathi SS, Raghuaram N, Tekur P, Joshi RR, Ramarao NH. Development and validation of integrated yoga module for obesity in adolescents. Int J Yoga. 2018;11(3):231–8.

    Article  PubMed  PubMed Central  Google Scholar 

  115. Rshikesan PB, Subramanyam P, Nidhi R. Yoga practice for reducing the male obesity and weight related psychological difficulties: a randomized controlled trail. J Clin Diagn Res. 2016;10:22–8.

    CAS  Google Scholar 

  116. Cramer H, Thoms MS, Anheyer D, Lauche R, Dobos G. Yoga in women with abdominal obesity: a randomised control trial. Dtsch Arztebl Int. 2016;30(113):654–2.

    Google Scholar 

  117. Telles S, Naveen VK, Balkrishna A, Kumar S. Short term health impact of yoga and diet change program on obesity. Med Sci Monit. 2010;16(1):CR35–40.

    CAS  PubMed  Google Scholar 

  118. Gokal R, Shilliton L, Maharaj SR. Positive impact of yoga and pranayama on obesity, hypertension, blood sugar and cholesterol: a pilot assessment. J Alter Complemet Med. 2007;13(10):1056–7.

    Article  Google Scholar 

  119. Dhananjai S, Sadashiv TS, Dutt K, Kumar R. Reducing psychological distress and obesity through yoga practice. Int J Yoga. 2013;6(1):66–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  120. Ross A, Thomas S. The health benefits of yoga and exercise: a review of comparison studies. J Alter Complement Med. 2010;16(1):3–12.

    Article  Google Scholar 

  121. Lee JA, Kim JW, Kim Y. Effects of yoga exercise on serum adiponectin and metabolic syndrome factors in obese postmenopausal women. Menopause. 2012;19(3):296–301.

    Article  PubMed  Google Scholar 

  122. Supriya R, et al. Yoga decreases anti-inflamatory adipokine in metabolic syndrome, high BP. Scand J Med Sci Sports. 2017;28(3):1130–8.

    Article  Google Scholar 

  123. Lee JA, Kim D. Effects of Hatha yoga exercise on serum leptin and metabolic syndrome factors in menopause obese middle-aged women. Journal of life scence. 2010;20(7):1100–6.

    Article  Google Scholar 

  124. Dilliraj G, Shanthi B, Kalai Selvi VS. Effects of yoga on “leptin-the satiety hormone” in the fight against the global threat-“obesity”. Scholars Acad J Biosci. 2019; https://doi.org/10.21276/sajb.2019.7.2.5.

  125. Yu AP, Ugwu FN, Tam BT, Lee PH, Lai CW, CSC W, Lam WW, Sheridan S, Sui PM. One year of Yoga training alters Ghrelin Axis in centrally obese adults with metabolic syndrome. Front Phsiol. 2018;9:1321.

    Article  Google Scholar 

  126. Papp ME, Lindfors P, Nygren-Bonnier M, Gullstrand L, Wandell PE. Effects of high-intensity hatha yoga on cardiovascular fitness, adipocytokines and apolipoproteins in healthy students: a randomized controlled study. J Altern Complement Med. 2016;22(1):81–7.

    Article  PubMed  PubMed Central  Google Scholar 

  127. International Diabetes Federation, Chapter 3, The global picture. In: IDF Diabetes Atlas. 8th ed. Brussels: International Diabetes Federation; 2017. p. 40–59.

    Google Scholar 

  128. Thangasami SR, Chandani AL, Thangasami S. Emphasis of yoga in the management of diabetes. J Diabetes Metab. 2015;6:613.

    Article  Google Scholar 

  129. Khalsa SB. Yoga as a therapeutic intervention: a bibliometric analysis of published research studies. Indian J Physiol Pharmacol. 2004;48:269–85.

    PubMed  Google Scholar 

  130. Raveendran AV, Deshpande A, Joshi SR. Therapeutic role of yoga in type 2 diabetes. Endocrinol Metab ( Seoul). 2018;33(3):307–17.

    Article  PubMed  PubMed Central  Google Scholar 

  131. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V, Indian Diabetes Prevention Programme (IDPP). The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006;49:289–97.

    Article  CAS  PubMed  Google Scholar 

  132. Sahay BK. Role of yoga in diabetes. J Assoc Physicians India. 2007;55:121–6.

    CAS  PubMed  Google Scholar 

  133. Youngwanichsetha S, Phumdoung S, Ingkathawornwong T. The effects of mindfulness eating and yoga exercise on blood sugar levels of pregnant women with gestational diabetes mellitus. Appl Nurs Res. 2014;27(4):227–30.

    Article  PubMed  Google Scholar 

  134. Hegde SV, Adhikari P, Shetty S, Manjrekar P, D’Souza V. Effect of community-based yoga intervention on oxidative stress and glycemic parameters in prediabetes: a randomized controlled trial. Complement Ther Med. 2013;21:571–6.

    Article  PubMed  Google Scholar 

  135. Rioux JG, Ritenbaugh C. Narrative review of yoga intervention clinical trials including weight-related outcomes. Altern Ther Health Med. 2013;19:32–46.

    PubMed  Google Scholar 

  136. Shantakumari N, Sequeira S, El deeb R. Effects of a yoga intervention on lipid profiles of diabetes patients with dyslipidemia. Indian Heart J. 2013;65:127–31.

    Article  PubMed  PubMed Central  Google Scholar 

  137. Hedge SV, Adhikari P, Shetty S, Manjrekar P, D’Souza V. Effect of community-based yoga intervention on oxidative stress and glycemic parameters in prediabetes: a randomized controlled trial. Complement Ther Med. 2013;21(6):571–6.

    Article  Google Scholar 

  138. Hegde SV, Adhikari P, Kotian S, Pinto VJ, D’Souza S, D’Souza V. Effect of 3-month yoga on oxidative stress in type 2 diabetes with or without complications. Diabetes Care. 2011;34(10):2208–10.

    Article  PubMed  PubMed Central  Google Scholar 

  139. Telles S, Naveen VK, Balkrishna A. Serum leptin, cholesterol and blood glucose levels in diabetics following a yoga and diet change program Comment to: Statins and beta-cell function Lei Qian, Lihong Xu, Yi Lin, Yongde Peng Med Sci Monit 2010;16:HY1-2. Med Sci Monit. 2010;16:LE4–5.

    PubMed  Google Scholar 

  140. Amita S, Prabhakar S, Manoj I, Harminder S, Pavan T. Effect of yoga-nidra on blood glucose level in diabetic patients. Indian J Physiol Pharmacol. 2009;53:97–101.

    CAS  PubMed  Google Scholar 

  141. Aljasir B, Bryson M, Al-Shehri B. Yoga practice for the management of Type II diabetes mellitus in adults: a systematic review. Evid Based Complement Alternat Med. 2010;7:399–408.

    Article  PubMed  Google Scholar 

  142. Singh S, Kyizom T, Singh KP, Tandon OP, Madhu SV. Influence of pranayamas and yoga-asanas on serum insulin, blood glucose and lipid profile in type 2 diabetes. Indian J Clin Biochem. 2008;23:365–8.

    Article  PubMed  PubMed Central  Google Scholar 

  143. Cohen BE, Chang AA, Grady D, Kanaya AM. Restorative yoga in adults with metabolic syndrome: a randomized, controlled pilot trial. Metab Syndr Relat Disord. 2008;6:223–9.

    Article  PubMed  PubMed Central  Google Scholar 

  144. Vinutha HT, Raghvendra BR, Manjumanth NK. Effect of integrated approach of yoga therapy on autonomic functions in patients with type 2 diabetes. Indian J Endocrinol Metab. 2015;19(5):653–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  145. Tyagi A, Cohen M. Yoga and heart rate variability: a comprehensive review of the literature. Int J Yoga. 2016;9(2):97–113.

    Article  PubMed  PubMed Central  Google Scholar 

  146. Innes KE, Vincent HK. The influence of yoga-based programs on risk profiles in adults with type 2 diabetes mellitus: a systematic review. Evid Based Complement Alternat Med. 2007;4:469–86.

    Article  PubMed  Google Scholar 

  147. Cardiovascular Diseases (CVDs) - World Health Organization www.who.int › Newsroom › Fact sheets › Detail. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).

  148. World Health Organization. Prioritizing a preventable epidemic. A primer for the media on non-communicable diseases; 2011. Available from http://www.wpro.who.int/noncommunicable_diseases/ncd_primer.pdf.

  149. Daubenmier JJ, Weidner G, Sumner MD, Mendell N, Merritt-Worden T, Studley J, et al. The contribution of changes in diet, exercise, and stress management to changes in coronary risk in women and men in the multisite cardiac lifestyle intervention program. Ann Behav Med. 2007;33(1):57–68.

    Article  PubMed  Google Scholar 

  150. Sarvottam Kand Yadav RK. Obesity-related inflammation & cardiovascular disease: efficacy of a yoga-based lifestyle intervention. Indian J Med Res. 2014;139(6):822–34.

    Google Scholar 

  151. Kloting N, Bluher M. Adipocyte dysfunction, inflammation and metabolic syndrome. Rev Endocr Metab Disord. 2014;15:277–87.

    Article  PubMed  CAS  Google Scholar 

  152. Yoo HJ, Choi KM. Adipokines as a novel link between obesity and atherosclerosis. World J Diabetes. 2014;5:357–63.

    Article  PubMed  PubMed Central  Google Scholar 

  153. Oh JY. Regional adiposity, adipokines, and insulin resistance in type 2 diabetes. Diabetes Metab J. 2012;36:412–4.

    Article  PubMed  PubMed Central  Google Scholar 

  154. Fasshauer M, Bluher M. Adipokines in health and disease. Trends Pharmacol Sci. 2015;36:461–70.

    Article  CAS  PubMed  Google Scholar 

  155. Xu A, Vanhoutte PM. Adiponectin and adipocyte fatty acid binding protein in the pathogenesis of cardiovascular disease. Am J Physiol Heart Circ Physiol. 2012;302:H1231–40.

    Article  CAS  PubMed  Google Scholar 

  156. Kralisch S, Fasshauer M. Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease? Diabetologia. 2013;56:10–21.

    Article  CAS  PubMed  Google Scholar 

  157. Supriya R, Yu AP, Lee PH, Lai CW, Cheng KK, Yau SY, Chan LW, Yung BY, Siu PM. Yoga training modulates adipokines in adults with high-normal blood pressure and metabolic syndrome. Scand J Med Sci Sports. 2018;28(3):1130–8.

    Article  PubMed  Google Scholar 

  158. Telles S, Sharma SK, Yadav SN, Balkrishna A. A comparative controlled trial comparing the effects of yoga and walking for overweight and obese adults. Med Sci Monit. 2014;20:894–904.

    Article  PubMed  PubMed Central  Google Scholar 

  159. Sarvottam K, Magan D, Yadav RK, Mehta N, Mahapatra SC. Adiponectin, Interleukin-6, and cardiovascular disease risk factors are modified by a short-term yoga-based lifestyle intervention in overweight and obese men. J Altern Complement Med. 2013;19(5):397–402.

    Article  PubMed  Google Scholar 

  160. Catoire M, Kersten S. The search for exercise factors in humans. FASEB J. 2015;29:1615.

    Article  CAS  PubMed  Google Scholar 

  161. Eckardt K, Gorgens SW, Raschke S, Eckel J. Myokines in insulin resistance and type 2 diabetes. Diabetologia. 2014;57:1087–99.

    Article  CAS  PubMed  Google Scholar 

  162. Chen YW, Apostolakis S, Lip GYH. Exercise-induced changes in inflammatory processes: Implications for thrombogenesis in cardiovascular disease. Ann Med. 2014;46(7):439–55.

    Article  CAS  PubMed  Google Scholar 

  163. Iroz A, Couty JP, Postic C. Hepatokines: unlocking the multiorgan network in metabolic diseases. Diabetologia. 2015;58:1699–703.

    Article  CAS  PubMed  Google Scholar 

  164. Weikert C, Stefan N, Schulze MB, Pischon T, Berger K, Joost HG, et al. Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke. Circulation. 2008;118:2555–62.

    Article  CAS  PubMed  Google Scholar 

  165. Ix JH, Wassel CL, Kanaya AM, Vittinghoff E, Johnson KC, Koster A, et al. Fetuin-A and incident diabetes mellitus in older persons. JAMA. 2008;300:182–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  166. Choi KM, Han KA, Ahn HJ, Lee SY, Hwang SY, Kim BH, et al. The effects of caloric restriction on fetuin-A and cardiovascular risk factors in rats and humans: a randomized controlled trial. Clin Endocrinol (Oxf). 2013;79:356–63.

    Article  CAS  Google Scholar 

  167. Yang SJ, Hwang SY, Choi HY, Yoo HJ, Seo JA, Kim SG, et al. Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis. J Clin Endocrinol Metab. 2011;96:E1325–9.

    Article  CAS  PubMed  Google Scholar 

  168. Kharitonenkov A, Adams AC. Inventing new medicines: the FGF21 story. Mol Metab. 2013;3:221–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  169. Gimeno RE, Moller DE. FGF21-based pharmacotherapy: potential utility for metabolic disorders. Trends Endocrinol Metab. 2014;25:303–11.

    Article  CAS  PubMed  Google Scholar 

  170. Stephens I. Medical yoga therapy. Children. 2017;4:12.

    Article  PubMed Central  Google Scholar 

  171. Sivasankaran S, Pollard-Quintner S, Sachdeva R, Pugeda J, Hoq SM, Zarich SW, et al. The effect of a six-week program of yoga and meditation on brachial artery reactivity: Do psychosocial interventions affect vascular tone? Clin Cardiol. 2006;29:393–8.

    Article  PubMed  Google Scholar 

  172. Bernardi L, Porta C, Spicuzza L, Bellwon J, Spadacini G, Frey AW, et al. Slow breathing increases arterial baroreflex sensitivity in patients with chronic heart failure. Circulation. 2002;105:143–5.

    Article  PubMed  Google Scholar 

  173. Madanmohan, Bhavanani AB, Prakash ES, Kamath MG, Amudhan J. Effect of six weeks of savasana training on spectral measures of short-term heart rate variability in young healthy volunteers. Indian J Physiol Pharmacol. 2004;48:370–3.

    CAS  PubMed  Google Scholar 

  174. Lakkireddy D, Atkins D, Pillarisetti J, et al. Effect of yoga on arrhythmia burden, anxiety, depression, and quality of life in paroxysmal atrial fibrillation: the YOGA My Heart Study. J Am Coll Cardiol. 2013;61(11):1177–82.

    Article  PubMed  Google Scholar 

  175. Wahlstrom M, Rydell Karlsson M, Medin J, Frykman V. Effects of yoga in patients with paroxysmal atrial fibrillation—a randomized controlled study. Eur J Cardiovasc Nurs. 2017;16:57–63.

    Article  PubMed  Google Scholar 

  176. Pal A, Srivastava N, Tiwari S, et al. Effect of yogic practices on lipid profile and body fat composition in patients of coronary artery disease. Complement Ther Med. 2011;19(3):122–7.

    Article  PubMed  Google Scholar 

  177. Cramer H, Lauche R, Haller H, Dobos G, Michalsen A. A systematic review of yoga for heart disease. Eur J Prev Cardiol. 2015;22(3):284–95.

    Article  PubMed  Google Scholar 

  178. Innes KE, Bourguignon C, Taylor AG. Risk indices associated with the insulin resistance syndrome, cardiovascular disease, and possible protection with Yoga: a systematic review. J Am Board Fam Pract. 2005;18:491–519.

    Article  PubMed  Google Scholar 

  179. Manna I. Effects of yoga training on body composition and oxidant-antioxidant status among healthy male. Int J Yoga. 2018;11(2):105–10.

    Article  PubMed  PubMed Central  Google Scholar 

  180. Shore R, Foster C, Pein R, Seebach E. Comparison of blood pressure lowering interventions. J Cardiopulm Rehabil. 2002;22:361–3.

    Google Scholar 

  181. Murugesan R, Govindarajulu N, Bera TK. Effect of selected yogic practices on the management of hypertension. Indian J Physiol Pharmacol. 2000;44:207–10.

    CAS  PubMed  Google Scholar 

  182. Nikam SV, Nikam PS, Suryakar AN, Badade ZG, Nikam K. Effect of pranayama practice on lipid peroxidation and antioxidants in coronary artery disease. Int J Biol Med Res. 2010;1(4):153–7.

    Google Scholar 

  183. Ornish D, Brown SE, Scherwitz LW, Billings JH, Armstrong WT, Ports TA, et al. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet. 1990;336:129–33.

    Article  CAS  PubMed  Google Scholar 

  184. Manchanda SC, Narang R, Reddy KS, Sachdeva U, Prabhakaran D, Dharmanand S, Rajani M, Bijlani R. Retardation of coronary atherosclerosis with yoga lifestyle intervention. J Assoc Phys India. 01 Jul 2000;48(7):687–94.

    CAS  Google Scholar 

  185. Yogendra J, Yogendra HJ, Ambardekar S, Lele RD, Shetty S, Dave M, et al. Beneficial effects of yoga lifestyle on reversibility of ischaemic heart disease: caring heart project of International Board of Yoga. J Assoc Physicians India. 2004;52:283–9.

    CAS  PubMed  Google Scholar 

  186. Goyal M, Singh S, Sibinga EM, Gould NF, Rowland-Seymour A, Sharma R, et al. Meditation programs for psychological stress and well-being: a systematic review and meta-analysis. JAMA Intern Med. 2014;174:357–68.

    Article  PubMed  PubMed Central  Google Scholar 

  187. Manchanda SC, Naranag R, Reddy KS, Sachdeva U, Prabhakaran D, Dharmanand S, et al. Reversal of coronary atherosclerosis by yoga lifestyle intervention. Front Cardiovasc Health. 2000;2000:535–47.

    Google Scholar 

  188. Eraballi A, Raghuram N, Ramarao NH, Pradhan B, Rao PV. Yoga based lifestyle program in improving quality of life after coronary artery bypass graft surgery: a randomised controlled trial. J Clin Diagnostic Res. 2018;12(3):5–9.

    Google Scholar 

  189. Schmidt T, Wijga A, Von Zur MA, Brabant G, Wagner TO. Changes in cardiovascular risk factors and hormones during a comprehensive residential three month kriya yoga training and vegetarian nutrition. Acta Physiol Scand Suppl. 1997;640:158–62.

    CAS  PubMed  Google Scholar 

  190. Gupta SK, Sawhney RC, Rai L, Chavan VD, Dani S, et al. Regression of coronary atherosclerosis through healthy lifestyle in coronary artery disease patients–Mount Abu open heart trial. Indian Heart J. 2011;63:461–9.

    PubMed  Google Scholar 

  191. Datey KK, Deshmukh SN, Dalvi CP, Vinekar SL. “Shavasan”: a yogic exercise in the management of hypertension. Angiology. 1969;20(6):325–33.

    Article  CAS  PubMed  Google Scholar 

  192. Sundar S, Agrawal SK, Singh VP, Bhattacharya SK, Udupa KN, Vaish SK. Role of yoga in management of essential hypertension. Acta Cardiol. 1984;39(3):203–8.

    CAS  PubMed  Google Scholar 

  193. Bagga OP, Gandhi A. A comparative study of the effect of Transcendental Meditation (TM) and Shavasana practice on cardiovascular system. Indian Heart J. 1983;35(1):39–45.

    CAS  PubMed  Google Scholar 

  194. Parati G, Steptoe A. Stress reduction and blood pressure control in hypertension: a role for transcendental meditation? J Hypertens. 2004;22(11):2057–60.

    Article  CAS  PubMed  Google Scholar 

  195. Rana Singh RK, Singh VK. Clinical evaluation of some yogic practices in the management of essential hypertension. Indian Med J. 2013;107(3):105.

    Google Scholar 

  196. Anderson JW, Liu C, Kryscio RJ. Blood pressure response to transcendental meditation: a meta-analysis. Am J Hypertens. 2008;21(3):310–6.

    Article  PubMed  Google Scholar 

  197. Stamler J, Rose G, Stamler R, Elliott P, Dyer A, Marmot M. INTERSALT study findings. Public health and medical care implications. Hypertension. 1989;14(5):570–7.

    Article  CAS  PubMed  Google Scholar 

  198. Appel LJ. Lifestyle modification as a means to prevent and treat high blood pressure. J Am Soc Nephrol. 2003;14(7 Suppl 2):S99–S102.

    Article  PubMed  Google Scholar 

  199. Selvamurthy W, Sridharan K, Ray US, Tiwary RS, Hegde KS, Radhakrishan U, et al. A new physiological approach to control essential hypertension. Indian J Physiol Pharmacol. 1998;42(2):205–13.

    CAS  PubMed  Google Scholar 

  200. Chaya MS, Kurpad AV, Nagendra HR, Nagarathna R. The effect of long term combined yoga practice on the basal metabolic rate of healthy adults. BMC Complement Altern Med. 2006;6:28.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  201. Boroughs LK, DeBerardinis RJ. Metabolic pathways promoting cancer cell survival. Nat Cell Biol. 2015;17:351–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  202. Ward PS, Patel J, Wise DR, Abdel-Wahab O, Bennett BD, Coller HA, et al. The common feature of leukemia-associated IDH1 and IDH 2 mutations is a neurotrophic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell. 2010;17:225–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  203. Korniluk A, Koper O, Kemona H, Dymicka-Piekarska V. From inflammation to cancer. Ir J Med Sci. 2017;186(1):57–62.

    Article  CAS  PubMed  Google Scholar 

  204. Mondal S. Science of exercise: ancient Indian origin. J Assoc Phys india. 2013;61:560–2.

    Google Scholar 

  205. Bhogal RS. Yoga and mental health and beyond. Lonavla, India: Published by Twari OP, Kaivalyadhama; 2018.

    Google Scholar 

  206. Chatterjee S, Mondal S. Modern theories of aging and contribution of yoga in its prevention – a critical review. Yoga Mimamsa. 2009;41(1):34–7.

    Google Scholar 

  207. Gore MM. Anatomy and Physiology of Yogic Practices, 4th revised and enlarged edition, 2019 (reprinted). Delhi, India: New Age Books.

    Google Scholar 

  208. Saraswati SS. Surya Namaskara: a technique of solar vitalization. Munger, Bihar, India: Yoga Publication Trust; 2007.

    Google Scholar 

  209. Sinha B, Ray US, Pathak A, Selvamurthy W. Energy cost and cardiovascular changes during the practice of Surya Namaskar. Indian J Physiol and Pharmacol. 2004;48:184–90.

    CAS  Google Scholar 

  210. Bhutkar PM, Bhutkar MV, Taware GB, Doijad V, Doddamani BR. Effect of suryanamaskar practice on cardio-respiratory fitness parameters: a pilot study. Al Ameen J Med Sci. 2008;1(2):126–9.

    Google Scholar 

  211. Ray US, Pathak A, Tomer OS. Hatha yoga practices: energy expenditure, respiratory changes and intensity of exercise. Evid Based Complement Altern Med. 2011;2011:241294.

    Article  Google Scholar 

  212. Coulter HD. Anatomy of Hatha Yoga. Delhi, India: Motilal Banarasidass Publishers Private Limited; 2001.

    Google Scholar 

  213. Maheshananda S, Kulkarni DD. Scientific exposition on pranayama: a review. Pali, Rajasthan, India: Chouhan GS, Arogyadhama; 2012.

    Google Scholar 

  214. Saoji AA, Raghavendra BR, Manjunath NK. Effects of yogic breath regulation: a narrative review of scientific evidence. J Ayurveda Integr Med. 2019;10:50–8.

    Article  PubMed  Google Scholar 

  215. Telles S, Gerberg P, Kozasa EH. Editorial: physiologic effects of mind and body practices. Biomed Res Int. 2015;2015:983068.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Physical Education, Jadavpur University, Kolkata, West Bengal, India

    Sridip Chatterjee & Puneet Bhattacharya

Authors
  1. Sridip Chatterjee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Puneet Bhattacharya
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sridip Chatterjee .

Editor information

Editors and Affiliations

  1. Cardiologist & Cardiac Electrophysiologist, Director of Cardiovascular Research, Memphis VA Medical Center, Memphis, TN, USA

    Indranill Basu-Ray

  2. Medical Director, Benson-Henry Institute for Mind Body Medicine & Director, Office for Well-Being, Center for Faculty Development, Massachusetts General Hospital, Boston, MA, USA

    Darshan Mehta

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Chatterjee, S., Bhattacharya, P. (2022). Cardiometabolic Syndrome and Effects of Yoga. In: Basu-Ray, I., Mehta, D. (eds) The Principles and Practice of Yoga in Cardiovascular Medicine. Springer, Singapore. https://doi.org/10.1007/978-981-16-6913-2_15

Download citation

  • DOI: https://doi.org/10.1007/978-981-16-6913-2_15

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-16-6912-5

  • Online ISBN: 978-981-16-6913-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation